当前位置:首页 - 行情中心 - 戴维医疗(300314) - 财务分析 - 现金流量表

戴维医疗

(300314)

  

流通市值:19.61亿  总市值:39.28亿
流通股本:1.44亿   总股本:2.88亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金395,264,661.47257,090,536.01113,489,644.1586,985,403.59
  收到的税费返还5,248,645.794,267,246.262,038,998.5410,769,559.19
  收到其他与经营活动有关的现金21,626,293.7714,556,785.499,447,438.5724,225,428.89
  经营活动现金流入小计422,139,601.03275,914,567.76124,976,081.21621,980,391.67
  购买商品、接受劳务支付的现金203,651,729.52134,109,672.2973,844,089.29243,350,927.69
  支付给职工以及为职工支付的现金101,116,347.0973,829,133.5647,752,405.84138,153,396.76
  支付的各项税费21,255,721.2414,664,665.518,833,790.6932,891,214.7
  支付其他与经营活动有关的现金81,311,564.7857,294,990.326,785,557.27113,718,041.38
  经营活动现金流出小计407,335,362.63279,898,461.66157,215,843.09528,113,580.53
  经营活动产生的现金流量净额14,804,238.4-3,983,893.9-32,239,761.8893,866,811.14
二、投资活动产生的现金流量:
  取得投资收益收到的现金134,837,568.47,232,314.014,987,890.27,027,933.37
  处置固定资产、无形资产和其他长期资产收回的现金净额56,548.6756,548.67-49,511.48
  收到的其他与投资活动有关的现金808,530,027.4652,900,000315,000,0001,080,000,000
  投资活动现金流入小计943,424,144.47660,188,862.68319,987,890.21,087,077,444.85
  购建固定资产、无形资产和其他长期资产支付的现金50,594,306.2637,480,130.1821,448,191.18139,689,208.26
  投资支付的现金---20,000,000
  支付其他与投资活动有关的现金820,229,333.32585,000,000315,000,0001,190,000,000
  投资活动现金流出小计870,823,639.58622,480,130.18336,448,191.181,349,689,208.26
  投资活动产生的现金流量净额72,600,504.8937,708,732.5-16,460,300.98-262,611,763.41
三、筹资活动产生的现金流量:
  分配股利、利润或偿付利息支付的现金25,056,0008,504,406.6-51,840,000
  支付其他与筹资活动有关的现金1,721,237.041,721,237.04-5,020,091.01
  筹资活动现金流出平衡项目00-0
  筹资活动现金流出小计26,777,237.0410,225,643.64-56,860,091.01
  筹资活动产生的现金流量净额平衡项目00-0
  筹资活动产生的现金流量净额-26,777,237.04-10,225,643.64--56,860,091.01
四、汇率变动对现金及现金等价物的影响-1,641,416.03641,658.04284,560.49-290,105.15
五、现金及现金等价物净增加额58,986,090.2224,140,853-48,415,502.37-225,895,148.43
  加:期初现金及现金等价物余额331,561,172.15331,561,172.15331,561,172.15557,456,320.58
  期末现金及现金等价物余额390,547,262.37355,702,025.15283,145,669.78331,561,172.15
补充资料:
  净利润-50,976,694.29-57,263,314.13
  资产减值准备-971,159.65-5,305,042.07
  固定资产和投资性房地产折旧-10,099,580.07-24,774,085.25
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-10,099,580.07-24,774,085.25
  无形资产摊销-1,119,803.68-1,947,096.03
  长期待摊费用摊销-1,991,109.14-3,560,471.63
  处置固定资产、无形资产和其他长期资产的损失-104,015.1-7,567.96
  固定资产报废损失-14,033.48-8,550.75
  公允价值变动损失----435,315.07
  财务费用--238,017.49--358,945.33
  投资损失--7,928,854.87-10,073,085.92
  递延所得税-202,117.73--1,973,619.6
  其中:递延所得税资产减少-202,117.73--1,973,619.6
  存货的减少--17,749,429.81--31,051,396.79
  经营性应收项目的减少--19,702,399.21--2,033,240.95
  经营性应付项目的增加--25,253,638.4-26,780,115.14
  现金的期末余额-355,702,025.15-331,561,172.15
  减:现金的期初余额-331,561,172.15-557,456,320.58
  现金及现金等价物的净增加额-24,140,853--225,895,148.43
公告日期2025-10-232025-08-222025-04-282025-04-09
审计意见(境内)标准无保留意见
TOP↑